Nirogacestat in Ovarian Granulosa Cell Tumors

Nirogacestat in Ovarian Granulosa Cell Tumors
Conditions:   Ovarian Granulosa-Stromal Tumor;   Ovarian Granulosa Cell Tumor;   Ovarian Cancer
Intervention:   Drug: Nirogacestat
Sponsor:   SpringWorks Therapeutics, Inc.

Source: View full study details on

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 16, 2022Comments | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine